Metastatic RCC Treated with Nivolumab: Tumor Progression or Pseudoprogression?

Event ESMO Preceptorship on Immuno-Oncology 2015
Session Session 5 Audience cases
Topics Cancer Immunology and Immunotherapy
Lung and other Thoracic Tumours
Presenter D, Mukherji, LB